مداوای علائم وازوموتور به منظور تشخیص زنان مبتلا به اختلالات خلقی
ترجمه نشده

مداوای علائم وازوموتور به منظور تشخیص زنان مبتلا به اختلالات خلقی

عنوان فارسی مقاله: درمان گروهی کنترل شده شناختی رفتاری برای مداوای علائم وازوموتور به منظور تشخیص زنان مبتلا به اختلالات خلقی
عنوان انگلیسی مقاله: Manualized cognitive behavioral group therapy to treat vasomotor symptoms for women diagnosed with mood disorders
مجله/کنفرانس: مجله تحقیقات روانشناختی - Journal Of Psychosomatic Research
رشته های تحصیلی مرتبط: روانشناسی
گرایش های تحصیلی مرتبط: روانشناسی بالینی، روانشناسی شناخت، روانشناسی عمومی
کلمات کلیدی فارسی: اضطراب - درمان شناختی رفتاری، گروه، گرگرفتگی - یائسگی، اختلالات خلقی
کلمات کلیدی انگلیسی: Anxiety - Cognitive behavior therapy، Group، Hot flashes - Menopause، Mood disorders
نوع نگارش مقاله: مقاله پژوهشی (Research Article)
شناسه دیجیتال (DOI): https://doi.org/10.1016/j.jpsychores.2019.109882
دانشگاه: Department of Psychiatry and Reproductive Biology, Case Western Reserve University School of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA
صفحات مقاله انگلیسی: 8
ناشر: الزویر - Elsevier
نوع ارائه مقاله: ژورنال
نوع مقاله: ISI
سال انتشار مقاله: 2020
ایمپکت فاکتور: 2/882 در سال 2019
شاخص H_index: 141 در سال 2020
شاخص SJR: 1/275 در سال 2019
شناسه ISSN: 0022-3999
شاخص Quartile (چارک): Q1 در سال 2019
فرمت مقاله انگلیسی: PDF
وضعیت ترجمه: ترجمه نشده است
قیمت مقاله انگلیسی: رایگان
آیا این مقاله بیس است: بله
آیا این مقاله مدل مفهومی دارد: ندارد
آیا این مقاله پرسشنامه دارد: ندارد
آیا این مقاله متغیر دارد: دارد
کد محصول: E14444
رفرنس: دارای رفرنس در داخل متن و انتهای مقاله
فهرست مطالب (انگلیسی)

Abstract

1- Objective

2- Methods

3- Primary outcomes

4- Secondary outcomes

5- Results

6- Discussion

7- Limitations and future research

8- Relevance to clinical practice

References

بخشی از مقاله (انگلیسی)

Abstract

Objective: This 6-week, prospective, single-arm study examined the feasibility, acceptability, and preliminary efficacy of cognitive behavioral group therapy in peri- and postmenopausal women with mood disorders (major depression or bipolar) and problematic vasomotor menopausal symptoms. Methods: 59 participants from an outpatient clinic with mood disorders and problematic vasomotor symptoms were enrolled. The primary outcomes were change from baseline to 6 weeks in Hot Flush Night Sweat Problem Rating, Hot Flash Related Daily Interference, and Quality of Life. Secondary outcomes were change in Hot Flush Frequency, depression, anxiety, perceived stress, anhedonia, beliefs and cognitive appraisals of menopause. ClinicalTrials.gov [identifier: NCT02860910]. Results: On the Hot Flush Night Sweat Problem Rating, 39.3% improved 2 or more points, which was clinically relevant. Changes in Quality of Life (p = .001) and the Hot Flash Related Daily Interference Scale were also significant (p < .001). Significant results were found on most secondary outcomes (hot flush frequency on the Hot Flush Daily Diary, depression, anxiety, perceived stress (p < .001) and anhedonia (p = .001). One of six subscales (control subscale) on the cognitive appraisal of menopause significantly improved (p < .001). Three subscales on the beliefs measure did not change significantly (p = .05, p = .91, and p = .14). Six-week study retention was robust (N = 55, 93%) and 94.2% of individuals reported that cognitive behavioral group therapy sessions were useful. Conclusion: This exploratory study suggests that CBGT is acceptable, feasible, and efficacious in women with mood disorders and problematic menopause vasomotor symptoms. Further studies are needed using more rigorous and controlled methods.

Objective

Menopause can be an important life transition for women. Physical symptoms may include vasomotor symptoms and irregular menstrual cycles [1]. Vasomotor symptoms also referred to as hot flashes and night sweats (HFNS), are the primary reason why women seek medical attention during menopause. Racial minorities, women with higher BMIs [2–4] and women with lower education levels [4] may be more vulnerable to menopause distress. There is an important link between psychological status and menopause associated with stress, anxiety, or depression [5,6]; and menopause may exacerbate psychiatric symptoms in those with pre-existing mental health conditions. The Study on Women's Health Across the Nation (SWAN) suggested that peri- and early postmenopausal women were at two-to-four-times greater risk for depressive episodes even after controlling for demographic and clinical characteristics [7]. Other risk factors for menopausal symptoms include stressful life events, psychological distress [8,9], higher perceived stress [10], depressive symptoms and negative affect [11]. Negative beliefs about menopause and vasomotor symptom severity have been associated with depressed symptoms during menopause [12,13].